Mallinckrodt to Provide Premier MR Agent for 3 Years

Jan. 4, 2007 -- Mallinckrodt Inc. announced that it has signed an agreement with Premier purchasing Partners, L.P. to provide imaging products to Premier member healthcare facilities over a three-year period, broadening the scope of Mallinckrodt products available to Premier patients.

The products in the agreement include Mallinckrodt’s OptiMARK (gadoversetamide injection) magnetic resonance contrast agent, plus Mallinckrodt’s complete portfolio of contrast media agents, radiopharmaceuticals, barium and injectors, all used to perform various diagnostic imaging procedures.